1. Home
  2. INSM
  3. INSM News

Latest Insmed Incorporated (INSM) News on July 26, 2024

These Signs Show Which Stocks Are Having A Hidden Rally, Says Mark Minervini
INSM

Investor's Business Daily

a day ago

These Signs Show Which Stocks Are Having A Hidden Rally, Says Mark Minervini

Insmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
INSM

Zacks

a day ago

Insmed (INSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

What Makes Insmed Incorporated (INSM) a Prospective Investment?
INSM

Insider Monkey

11 days ago

What Makes Insmed Incorporated (INSM) a Prospective Investment?

INSM

MT Newswires

16 days ago

Goldman Sachs Raises Price Target on Insmed to $102 From $74, Maintains Buy Rating

INSM

MT Newswires

17 days ago

Guggenheim Adjusts Price Target on Insmed to $95 From $70, Maintains Buy Rating

INSM

MT Newswires

18 days ago

HC Wainwright Adjusts Price Target on Insmed to $90 From $70, Maintains Buy Rating

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
INSM

PR Newswire

21 days ago

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

More endpoints met in Insmed’s Phase III brensocatib trial
INSM

Clinical Trials Arena

23 days ago

More endpoints met in Insmed’s Phase III brensocatib trial

INSM

MT Newswires

23 days ago

Insmed Presenting More Positive Data for Prospective Drug Treatment for Bronchiectasis This Week

Additional Positive Data from Pivotal ASPEN Study of Brensocatib in Patients with Bronchiectasis to be Presented at the 7th World Bronchiectasis Conference
INSM

PR Newswire

23 days ago

Additional Positive Data from Pivotal ASPEN Study of Brensocatib in Patients with Bronchiectasis to be Presented at the 7th World Bronchiectasis Conference

Pharma companies shape competitive pipeline for bronchiectasis
INSM

Clinical Trials Arena

24 days ago

Pharma companies shape competitive pipeline for bronchiectasis

INSM

MT Newswires

a month ago

Truist Adjusts Insmed PT to $88 From $68, Updates Model Post Commercial Day; Maintains Buy Rating

Insmed Announces Redemption of all $225 Million of Outstanding 1.75% Convertible Senior Notes Due 2025
INSM

PR Newswire

a month ago

Insmed Announces Redemption of all $225 Million of Outstanding 1.75% Convertible Senior Notes Due 2025

INSM

MT Newswires

a month ago

Evercore ISI Boosts Price Target on Insmed to $75 From $42, Maintains Outperform Rating

INSM

MT Newswires

a month ago

JPMorgan Raises Insmed's Price Target to $72 From $55, Maintains Overweight Rating

Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing
INSM

BioPharma Dive

a month ago

Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing

INSM

MT Newswires

a month ago

Insmed Insider Sold Shares Worth $1,271,700, According to a Recent SEC Filing

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers
INSM

GOBankingRates

2 months ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia
INSM

Business Insider

2 months ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women
INSM

Insider Monkey

2 months ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase
INSM

Reuters

2 months ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

INSM

Insider Monkey

2 months ago

Best Date Night Fragrance in 2024

France's Macron calls snap legislative elections after EU poll blow
INSM

AFP

2 months ago

France's Macron calls snap legislative elections after EU poll blow

Dow Jones Futures Due; Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events
INSM

Investor's Business Daily

2 months ago

Dow Jones Futures Due; Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events

European Union Vote Delivers Shift to Right, in Blow to French and German Governments
INSM

The Wall Street Journal

2 months ago

European Union Vote Delivers Shift to Right, in Blow to French and German Governments

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
INSM

PR Newswire

2 months ago

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

INSM

MT Newswires

2 months ago

Insmed Insider Sold Shares Worth $3,043,150, According to a Recent SEC Filing

INSM

MT Newswires

2 months ago

UBS Raises Price Target on Insmed to $78 From $58, Maintains Buy Rating

INSM

MT Newswires

2 months ago

Stifel Adjusts Price Target on Insmed to $74 From $67, Maintains Buy Rating

Insmed To Present at the Goldman Sachs 45th Annual Global Healthcare Conference
INSM

PR Newswire

2 months ago

Insmed To Present at the Goldman Sachs 45th Annual Global Healthcare Conference

INSM

MT Newswires

2 months ago

Stifel Adjusts Price Target on Insmed to $67 From $39, Maintains Buy Rating

INSM

MT Newswires

2 months ago

Insmed Insider Sold Shares Worth $1,362,075, According to a Recent SEC Filing

INSM

MT Newswires

2 months ago

Insmed Insider Sold Shares Worth $6,316,579, According to a Recent SEC Filing

INSM

MT Newswires

2 months ago

Insmed Insider Sold Shares Worth $12,064,607, According to a Recent SEC Filing

INSM

MT Newswires

2 months ago

Insmed Insider Sold Shares Worth $2,215,081, According to a Recent SEC Filing

Insmed to Host Commercial Webinar on June 4, 2024
INSM

PR Newswire

2 months ago

Insmed to Host Commercial Webinar on June 4, 2024

INSM

MT Newswires

2 months ago

Insmed Prices $650 Million Public Offering

Insmed Announces Pricing of $650 Million Public Offering of Common Stock
INSM

PR Newswire

2 months ago

Insmed Announces Pricing of $650 Million Public Offering of Common Stock

Insmed (INSM) Stock Soars 118% on Upbeat Lung Disease Drug Data
INSM

Zacks

2 months ago

Insmed (INSM) Stock Soars 118% on Upbeat Lung Disease Drug Data

INSM

MT Newswires

2 months ago

Wolfe Research Adjusts Price Target on Insmed to $54 From $42, Maintains Outperform Rating

INSM

MT Newswires

2 months ago

Morgan Stanley Adjusts Price Target on Insmed to $60 From $43, Maintains Overweight Rating

INSM

MT Newswires

2 months ago

TD Cowen Adjusts Insmed Price Target to $67 From $45, Maintains Buy Rating

INSM

MT Newswires

2 months ago

Goldman Sachs Adjusts Insmed Price Target to $74 From $49, Maintains Buy Rating

Insmed Announces Proposed $500 Million Public Offering of Common Stock
INSM

PR Newswire

2 months ago

Insmed Announces Proposed $500 Million Public Offering of Common Stock

The Next Humira? Insmed Catapults 119% On Its 'Very Attractive' Opportunity In Lung Disease.
INSM

Investor's Business Daily

2 months ago

The Next Humira? Insmed Catapults 119% On Its 'Very Attractive' Opportunity In Lung Disease.

INSM

MT Newswires

2 months ago

Sector Update: Health Care

Insmed stock blasts off over lung condition study results
INSM

Yahoo Finance Video

2 months ago

Insmed stock blasts off over lung condition study results

Insmed Stock Surges on Trial Win for Lung-Condition Drug. ‘We Hit the Mark,’ CEO Says.
INSM

Barrons.com

2 months ago

Insmed Stock Surges on Trial Win for Lung-Condition Drug. ‘We Hit the Mark,’ CEO Says.

INSM

MT Newswires

2 months ago

Top Midday Gainers

Stocks to Watch Tuesday: GameStop, Apple, Nvidia, Hess
INSM

The Wall Street Journal

2 months ago

Stocks to Watch Tuesday: GameStop, Apple, Nvidia, Hess

INSM

Associated Press Finance

2 months ago

Insmed, Agios rise; DraftKings, Atlantica fall, Tuesday, 5/28/2024

Why Is Inflammatory Diseased-Focused Insmed Stock Soaring On Tuesday?
INSM

Benzinga

2 months ago

Why Is Inflammatory Diseased-Focused Insmed Stock Soaring On Tuesday?

INSM

MT Newswires

2 months ago

Insmed Lung Infections Treatment Study Shows Improvement

Insmed Presents Positive Patient-Reported Outcomes and Microbiologic Data from Phase 3 ARISE Study Of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with NTM Lung Disease Caused by MAC at American Thoracic Society 2024 International Conference Plenary Session
INSM

PR Newswire

2 months ago

Insmed Presents Positive Patient-Reported Outcomes and Microbiologic Data from Phase 3 ARISE Study Of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with NTM Lung Disease Caused by MAC at American Thoracic Society 2024 International Conference Plenary Session

Insider Sale: Chief Medical Officer Martina Flammer Sells Shares of Insmed Inc (INSM)
INSM

GuruFocus.com

2 months ago

Insider Sale: Chief Medical Officer Martina Flammer Sells Shares of Insmed Inc (INSM)

INSM

MT Newswires

2 months ago

Goldman Sachs Adjusts Price Target on Insmed to $49 From $40, Maintains Buy Rating

Insmed Incorporated (NASDAQ:INSM) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
INSM

Simply Wall St.

3 months ago

Insmed Incorporated (NASDAQ:INSM) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Insmed Incorporated (NASDAQ:INSM) Q1 2024 Earnings Call Transcript
INSM

Insider Monkey

3 months ago

Insmed Incorporated (NASDAQ:INSM) Q1 2024 Earnings Call Transcript

Insmed Inc (INSM) Reports Q1 2024 Earnings: Misses EPS Estimates, Revenue Grows Amidst Clinical ...
INSM

GuruFocus.com

3 months ago

Insmed Inc (INSM) Reports Q1 2024 Earnings: Misses EPS Estimates, Revenue Grows Amidst Clinical ...

Insmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates
INSM

Zacks

3 months ago

Insmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates

INSM

MT Newswires

3 months ago

Mizuho Securities Raises Price Target on Insmed to $36 From $35, Keeps Buy Rating

Insmed First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
INSM

Simply Wall St.

3 months ago

Insmed First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Insmed (INSM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
INSM

Zacks

3 months ago

Insmed (INSM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Insmed (INSM) Reports Q1 Loss, Lags Revenue Estimates
INSM

Zacks

3 months ago

Insmed (INSM) Reports Q1 Loss, Lags Revenue Estimates

INSM

MT Newswires

3 months ago

Insmed's Q1 Net Loss Narrows as Revenue Advances

INSM

Associated Press Finance

3 months ago

Insmed: Q1 Earnings Snapshot

Insmed Reports First-Quarter 2024 Financial Results and Provides Business Update
INSM

PR Newswire

3 months ago

Insmed Reports First-Quarter 2024 Financial Results and Provides Business Update

Should You Buy Insmed (INSM) Ahead of Earnings?
INSM

Zacks

3 months ago

Should You Buy Insmed (INSM) Ahead of Earnings?

Will Tango Therapeutics, Inc. (TNGX) Report Negative Q1 Earnings? What You Should Know
INSM

Zacks

3 months ago

Will Tango Therapeutics, Inc. (TNGX) Report Negative Q1 Earnings? What You Should Know

Insmed To Present at the BofA Securities Health Care Conference 2024
INSM

PR Newswire

3 months ago

Insmed To Present at the BofA Securities Health Care Conference 2024

We Think Some Shareholders May Hesitate To Increase Insmed Incorporated's (NASDAQ:INSM) CEO Compensation
INSM

Simply Wall St.

3 months ago

We Think Some Shareholders May Hesitate To Increase Insmed Incorporated's (NASDAQ:INSM) CEO Compensation

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
INSM

PR Newswire

3 months ago

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Insmed (INSM) Expected to Beat Earnings Estimates: Should You Buy?
INSM

Zacks

3 months ago

Insmed (INSM) Expected to Beat Earnings Estimates: Should You Buy?

Insmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024
INSM

PR Newswire

3 months ago

Insmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024

What Makes Insmed (INSM) a Lucrative Investment?
INSM

Insider Monkey

4 months ago

What Makes Insmed (INSM) a Lucrative Investment?

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
INSM

PR Newswire

4 months ago

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Insmed to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference
INSM

PR Newswire

4 months ago

Insmed to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
INSM

PR Newswire

5 months ago

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Insmed To Present at Three March Conferences
INSM

PR Newswire

5 months ago

Insmed To Present at Three March Conferences

Actress Jane Seymour and Insmed Raise Awareness of "Unseenism" and Empower People to Speak Up When It Comes to Their Health
INSM

PR Newswire

5 months ago

Actress Jane Seymour and Insmed Raise Awareness of "Unseenism" and Empower People to Speak Up When It Comes to Their Health

Insmed Full Year 2023 Earnings: EPS Misses Expectations
INSM

Simply Wall St.

5 months ago

Insmed Full Year 2023 Earnings: EPS Misses Expectations

Insmed Incorporated (NASDAQ:INSM) Q4 2023 Earnings Call Transcript
INSM

Insider Monkey

5 months ago

Insmed Incorporated (NASDAQ:INSM) Q4 2023 Earnings Call Transcript

INSM

Thomson Reuters StreetEvents

5 months ago

Q4 2023 Insmed Inc Earnings Call

INSM

GuruFocus.com

5 months ago

Insmed (INSM) Reports Q4 Loss, Misses Revenue Estimates
INSM

Zacks

5 months ago

Insmed (INSM) Reports Q4 Loss, Misses Revenue Estimates

INSM

Associated Press Finance

5 months ago

Insmed: Q4 Earnings Snapshot

Insmed Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Business Update
INSM

PR Newswire

5 months ago

Insmed Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Business Update

Insmed (INSM) Expected to Beat Earnings Estimates: Should You Buy?
INSM

Zacks

5 months ago

Insmed (INSM) Expected to Beat Earnings Estimates: Should You Buy?

Insmed to Host Fourth-Quarter and Full Year 2023 Financial Results Conference Call on Thursday, February 22, 2024
INSM

PR Newswire

6 months ago

Insmed to Host Fourth-Quarter and Full Year 2023 Financial Results Conference Call on Thursday, February 22, 2024

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
INSM

PR Newswire

6 months ago

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

INSM

Thomson Reuters StreetEvents

6 months ago

Q4 2023 Landstar System Inc Earnings Call

INSM

Morningstar Research

6 months ago

Analyst Report: Landstar System, Inc.

Landstar says 2 more quarters before recovery
INSM

FreightWaves

6 months ago

Landstar says 2 more quarters before recovery

Despite shrinking by US$218m in the past week, ATI (NYSE:ATI) shareholders are still up 127% over 3 years
INSM

Simply Wall St.

6 months ago

Despite shrinking by US$218m in the past week, ATI (NYSE:ATI) shareholders are still up 127% over 3 years

A Motley Fool Co-Founder's Roller-Coaster Nvidia Story
INSM

Motley Fool

6 months ago

A Motley Fool Co-Founder's Roller-Coaster Nvidia Story

Automotive Telematics Market to Exceed USD 34.52 billion by 2031 | According to Transparency Market Research Analysis
INSM

GlobeNewswire

6 months ago

Automotive Telematics Market to Exceed USD 34.52 billion by 2031 | According to Transparency Market Research Analysis

United Arab Emirates Smart Manufacturing Market Analysis Showcases Growth Trends and Opportunities up to 2030
INSM

GlobeNewswire

6 months ago

United Arab Emirates Smart Manufacturing Market Analysis Showcases Growth Trends and Opportunities up to 2030

SoFi Stock Soars After Company Posts First-Ever Quarterly Profit
INSM

Barrons.com

6 months ago

SoFi Stock Soars After Company Posts First-Ever Quarterly Profit

Is There An Opportunity With Olin Corporation's (NYSE:OLN) 25% Undervaluation?
INSM

Simply Wall St.

6 months ago

Is There An Opportunity With Olin Corporation's (NYSE:OLN) 25% Undervaluation?

INSM

Thomson Reuters StreetEvents

6 months ago

Q4 2023 Olin Corp Earnings Call

Share on Social Networks: